Related Experiment Video
Updated: Jun 14, 2026

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
Published on: April 11, 2016
Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction
Simon Tual-Chalot1, Christelle Guibert, Bernard Muller
1CNRS UMR 6214, Faculté de Médecine, Rue Haute de Reculée, Angers, F-49045 France.
Rationale:
Pulmonary arterial hypertension (PAH) is a severe disease characterized by an increase of pulmonary vascular resistance, which is accompanied by functional and structural changes in pulmonary arteries. Microparticles (MPs) have been described as biological vector of endothelial dysfunction in other pathologies.
Objectives:
The purpose of this work was to characterize circulating MPs during hypoxic PAH and to study their effects on endothelial function.
Methods:
Male Wistar rats were exposed or not to chronic hypoxia, and normoxic or hypoxic MPs from blood were characterized by flow cytometry. Endothelial cells (ECs) from rat aorta or pulmonary arteries were incubated with MPs, and then expression and phosphorylation of enzymes involved in nitric oxide (NO) and reactive oxygen species productions were analyzed. Hypoxic MPs were injected into rats, and endothelium-dependent relaxation was assessed.
Measurements And Main Results:
Circulating levels of MPs from hypoxic rats were twofold higher than those present in normoxic rats. In vitro treatment of ECs with hypoxic MPs reduced NO production in aortas and pulmonary arteries by enhancing phosphorylation of endothelial NO synthase at the inhibitory site. Hypoxic MPs increased oxidative stress only in pulmonary ECs via xanthine oxidase and mitochondrial implication. In vivo injection of hypoxic MPs into rat impaired endothelium-dependent relaxation both in aorta and pulmonary arteries.
Conclusions:
These data provide evidence that hypoxic circulating MPs induce endothelial dysfunction in rat aorta and pulmonary arteries by decreasing NO production. Moreover, MPs display tissue specificity with respect to increased oxidative stress, which occurs only in pulmonary ECs.
Insights
Hypoxic microparticles (MPs) increase in pulmonary arterial hypertension (PAH), causing endothelial dysfunction by reducing nitric oxide (NO) production. These MPs show tissue specificity, increasing oxidative stress only in pulmonary endothelial cells.
Area of Science:
- Cardiovascular Research
- Endothelial Biology
- Pulmonary Hypertension
Background:
- Pulmonary arterial hypertension (PAH) involves increased pulmonary vascular resistance and arterial remodeling.
- Microparticles (MPs) are implicated as vectors of endothelial dysfunction in various diseases.
Purpose of the Study:
- Characterize circulating MPs in hypoxic PAH models.
- Investigate the impact of MPs on endothelial function.
Main Methods:
- Rats exposed to chronic hypoxia to induce PAH.
- Characterization of normoxic and hypoxic MPs via flow cytometry.
- In vitro incubation of endothelial cells (ECs) with MPs.
- Analysis of nitric oxide (NO) and reactive oxygen species (ROS) pathways.
- In vivo assessment of endothelium-dependent relaxation.
Main Results:
- Hypoxic rats exhibited a twofold increase in circulating MPs.
- MPs from hypoxic rats reduced NO production in aortic and pulmonary ECs by enhancing eNOS phosphorylation.
- Hypoxic MPs elevated oxidative stress specifically in pulmonary ECs via xanthine oxidase and mitochondrial pathways.
- In vivo administration of hypoxic MPs impaired endothelium-dependent relaxation in both aorta and pulmonary arteries.
Conclusions:
- Circulating MPs in hypoxic PAH induce endothelial dysfunction by decreasing NO bioavailability.
- MPs exhibit tissue specificity, exacerbating oxidative stress predominantly in pulmonary ECs.
- These findings highlight MPs as key players in PAH-associated endothelial dysfunction.
More Related Videos
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension II: Pathophysiology
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...